|
Tumorigenicity of MPM cell lines after orthotopic and subcutaneous implantation in nude mice. |
|||||
| Cell line |
Histology |
Tumorigenicity |
Implantation method |
Survival(days) (mean ± SD) |
Survival (days) (Min/Max) |
|
|
|||||
| IST-Mes2 |
Epithelioid |
0/15 |
Orthotopic |
- |
- |
| Epithelioid |
0/15 |
Subcutaneous |
- |
- |
|
| IST-Mes3 |
Biphasic |
15/15 |
Orthotopic |
81,5 ± 21,7 |
60/122 |
| Biphasic |
15/15 |
Subcutaneous |
Sacrificed after 90 days |
- |
|
| IST-Mes3/2P |
Biphasic |
15/15 |
Orthotopic |
69,6 ± 14,5 |
54/89 |
| MM-B1 |
Biphasic |
15/15 |
Orthotopic |
72,5 ± 6,4 |
68/77 |
| Biphasic |
0/15 |
Subcutaneous |
- |
- |
|
|
2 × 106 MPM cells were injected into the pleural cavity of nude mice. The experiment ended when mice were moribund. | |||||
Martarelli et al. BMC Cancer 2006 6:130 doi:10.1186/1471-2407-6-130 |
|||||